Related Experiment Video

Updated: Mar 12, 2026

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.4K

AMPK and Cancer

Zhiyu Wang1, Neng Wang2, Pengxi Liu3

  • 1Department of Mammary Disease, Guangdong Provincial Hospital of Chinese Medicine, The Second Clinical Collage of Guangzhou University of Chinese Medicine, Guangzhou, China. wangzhiyu976@126.com.

Experientia Supplementum (2012)
|November 5, 2016
PubMed

Insights

AMP-activated protein kinase (AMPK) acts as a stress-response molecule, inhibiting cancer growth but also promoting drug resistance. Targeting AMPK offers a new strategy for cancer prevention and treatment.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cellular Stress Response

Background:

  • AMP-activated protein kinase (AMPK) is a key cellular energy sensor.
  • Its role in cancer is complex, involving both tumor suppression and promotion of drug resistance.

Purpose of the Study:

  • To elucidate the dual role of AMPK in carcinogenesis and cancer drug resistance.
  • To explore AMPK as a therapeutic target for cancer treatment.

Main Methods:

  • Review of existing literature on AMPK signaling pathways.
  • Analysis of AMPK's interaction with tumor suppressors (LKB1, P53) and oncogenic pathways (mTOR, Akt).
  • Examination of AMPK's involvement in chemoresistance mechanisms (ABCG2, autophagy, cancer stem cells).

Main Results:

  • AMPK activation, linked to LKB1 and P53, inhibits cell growth and arrests the cell cycle.
  • Conversely, AMPK contributes to cancer drug resistance by influencing ABCG2 expression, autophagy, and cancer stem cell enrichment.
  • AMPK's complex role highlights its significance in cancer progression and treatment failure.

Conclusions:

  • AMPK exhibits a dichotomous role in cancer, acting as both a tumor suppressor and a facilitator of drug resistance.
  • Targeting AMPK presents a promising novel strategy for cancer prevention and therapeutic intervention.
  • Further research into AMPK modulation is crucial for effective cancer treatment development.
Keywords:
AMPKCancer drug resistanceCancer prevetionCarcinogenesisStress-response

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

890
Identification of Kinase-substrate Pairs Using High Throughput Screening11:13

Identification of Kinase-substrate Pairs Using High Throughput Screening

Published on: August 29, 2015

8.6K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.1K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

4.2K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.9K